![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1273, 2001-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New alternatives for the treatment of Crohn's disease?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antimycobacterials beneficial in Crohn's disease?
Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Can certolizumab pegol cure Crohn's disease?
Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ropinirole a good option in early Parkinson's disease?
Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pramipexole: treatment of choice in early Parkinson's disease?
Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. :